{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:06:07Z","timestamp":1790996767292,"version":"4.1.0"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.exer.2025.110364","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T01:34:46Z","timestamp":1743212086000},"page":"110364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Bilosomes as a novel ocular drug delivery system: Assessing the material attributes, process parameters, and quality attributes"],"prefix":"10.1016","volume":"255","author":[{"given":"Nisha","family":"Rajbhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devansh","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsh P.","family":"Nijhawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govind","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1620-0547","authenticated-orcid":false,"given":"Khushwant S.","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.exer.2025.110364_bib1","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ijpharm.2016.10.006","article-title":"Fabrication of novel ultradeformable bilosomes for enhanced ocular delivery of terconazole: in vitro characterization, ex vivo permeation and in vivo safety assessment","volume":"513","author":"Abdelbary","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.exer.2025.110364_bib2","article-title":"Bile salt stabilized nanovesicles as a promising drug delivery technology: a general overview and future perspectives","volume":"79","author":"Abdel-moneum","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.exer.2025.110364_bib3","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2019.01.070","article-title":"Mucoadhesive olaminosomes: a novel prolonged release nanocarrier of agomelatine for the treatment of ocular hypertension","volume":"560","author":"Abd-Elsalam","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.exer.2025.110364_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2004.10.026","article-title":"Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system","volume":"290","author":"Aggarwal","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.exer.2025.110364_bib5","article-title":"Ischemic brain treated with 6-gingerol loaded mucoadhesive nanoemulsion via intranasal delivery and their comparative pharmacokinetic effect in brain","volume":"61","author":"Ahmad","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.exer.2025.110364_bib6","doi-asserted-by":"crossref","first-page":"9783","DOI":"10.2147\/IJN.S278688","article-title":"Bilosomes as promising nanovesicular carriers for improved transdermal delivery: construction, in vitro optimization, ex vivo permeation and in vivo evaluation","volume":"15","author":"Ahmed","year":"2020","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.exer.2025.110364_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10717544.2020.1859000","article-title":"Utilization of PEGylated cerosomes for effective topical delivery of fenticonazole nitrate: in-vitro characterization, statistical optimization, and in-vivo assessment","volume":"28","author":"Albash","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.exer.2025.110364_bib8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.54133\/ajms.v5i.176","article-title":"Effects of different types of bile salts on the physical properties of ropinirole-loaded bilosomes","volume":"5","author":"Ali","year":"2023","journal-title":"Al-Rafidain Journal of Medical Sciences"},{"key":"10.1016\/j.exer.2025.110364_bib9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.54133\/ajms.v5i.176","article-title":"Effects of different types of bile salts on the physical properties of ropinirole-loaded bilosomes","volume":"5","author":"Ali","year":"2023","journal-title":"Al-Rafidain Journal of Medical Sciences"},{"issue":"1\u20132","key":"10.1016\/j.exer.2025.110364_bib10","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ijpharm.2014.06.041","article-title":"Nano-transfersomal ciprofloxacin loaded vesicles for non-invasive trans-tympanic ototopical delivery: in-vitro optimization, ex-vivo permeation studies, and in-vivo assessment","volume":"472","author":"Al-Mahallawi","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.exer.2025.110364_bib11","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/gels8110687","article-title":"Development of ciprofloxacin-loaded bilosomes in-situ gel for ocular delivery: optimization, in-vitro characterization, ex-vivo permeation, and antimicrobial study","volume":"8","author":"Alsaidan","year":"2022","journal-title":"Gels"},{"key":"10.1016\/j.exer.2025.110364_bib12","article-title":"Novel probe sonication method for the preparation of meloxicam bilosomes for transdermal delivery: Part One","volume":"vol. 11","author":"Al-Sawaf","year":"2023"},{"issue":"11","key":"10.1016\/j.exer.2025.110364_bib13","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.3109\/03639041003801885","article-title":"Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery","volume":"36","author":"Ammar","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.exer.2025.110364_bib14","article-title":"A comprehensive review on bilosome: a nano-vesicular drug delivery system to enhance bioavailability of the drug through different routes of administration","volume":"47","author":"Ashraf Nemr","year":"2024","journal-title":"Bull. Pharm. Sci., Assiut University"},{"key":"10.1016\/j.exer.2025.110364_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120451","article-title":"Thiolated cyclodextrins: mucoadhesive and permeation enhancing excipients for ocular drug delivery","volume":"599","author":"Asim","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.exer.2025.110364_bib16","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3390\/ph17040511","article-title":"Vesicular drug delivery systems: promising approaches in ocular drug delivery","volume":"17","author":"Batur","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.exer.2025.110364_bib17","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3390\/ph17040511","article-title":"Vesicular drug delivery systems: promising approaches in ocular drug delivery","volume":"17","author":"Batur","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.exer.2025.110364_bib18","first-page":"113","volume":"vol. 29","author":"Bhattacharjee","year":"2018"},{"issue":"9","key":"10.1016\/j.exer.2025.110364_bib19","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.3390\/ph15091043","article-title":"Bilosomes as nanoplatform for oral delivery and modulated in vivo antimicrobial activity of lycopene","volume":"15","author":"Binsuwaidan","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"1\u20132","key":"10.1016\/j.exer.2025.110364_bib20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0378-5173(02)00080-7","article-title":"Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin","volume":"238","author":"Cavalli","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.exer.2025.110364_bib21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.colsurfb.2016.03.061","article-title":"The potential use of novel chitosan-coated deformable liposomes in an ocular drug delivery system","volume":"143","author":"Chen","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"20\u201322","key":"10.1016\/j.exer.2025.110364_bib22","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1016\/S0264-410X(00)00537-5","article-title":"Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes)","volume":"19","author":"Conacher","year":"2001","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.exer.2025.110364_bib23","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3109\/10837450.2015.1091839","article-title":"Development of gatifloxacin-loaded cationic polymeric nanoparticles for ocular drug delivery","volume":"21","author":"Duxfield","year":"2016","journal-title":"Pharmaceut. Dev. Technol."},{"issue":"7","key":"10.1016\/j.exer.2025.110364_bib24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.9734\/jpri\/2024\/v36i77541","article-title":"Improved topical antifungal medication using sertaconazole bilosomes: in vitro permeability, cytotoxicity, and clinical assessment","volume":"36","author":"Eldemiri","year":"2024","journal-title":"Journal of Pharmaceutical Research International"},{"issue":"1","key":"10.1016\/j.exer.2025.110364_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08982104.2019.1577256","article-title":"Bilosomes as a novel carrier for the cutaneous delivery for dapsone as a potential treatment of acne: preparation, characterization and in vivo skin deposition assay","volume":"30","author":"El-Nabarawi","year":"2020","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.exer.2025.110364_bib26","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ijpharm.2019.04.069","article-title":"Anionic versus cationic bilosomes as oral nanocarriers for enhanced delivery of the hydrophilic drug risedronate","volume":"564","author":"Elnaggar","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.exer.2025.110364_bib27","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1208\/s12249-024-02962-z","article-title":"Vesicular carriers for improved oral anticoagulation competence of rivaroxaban: in vitro and in vivo investigation","volume":"25","author":"Faheim","year":"2024","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.exer.2025.110364_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1080\/10717544.2020.1858997","article-title":"Statistical optimization of hyaluronic acid enriched ultradeformable elastosomes for ocular delivery of voriconazole via Box-Behnken design: in vitro characterization and in vivo evaluation","volume":"28","author":"Fahmy","year":"2021","journal-title":"Drug Deliv."},{"issue":"2","key":"10.1016\/j.exer.2025.110364_bib29","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1517\/17425247.3.2.275","article-title":"Ocular drug delivery","volume":"3","author":"Ghate","year":"2006","journal-title":"Expet Opin. Drug Deliv."},{"issue":"3","key":"10.1016\/j.exer.2025.110364_bib30","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1124\/jpet.119.256933","article-title":"Ocular drug delivery: present innovations and future challenges","volume":"370","author":"Gote","year":"2019","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"6","key":"10.1016\/j.exer.2025.110364_bib31","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/ICU.0b013e32833f00dc","article-title":"Obstructive sleep apnea and ocular disorders","volume":"21","author":"Grover","year":"2010","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.exer.2025.110364_bib32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/B978-0-323-91864-0.00004-8","article-title":"Bilosomes: a novel platform for drug delivery","author":"Gupta","year":"2022","journal-title":"Systems of Nanovesicular Drug Delivery"},{"key":"10.1016\/j.exer.2025.110364_bib33","article-title":"Tailoring of berberine loaded transniosomes for the management of skin cancer in mice","volume":"60","author":"Gupta","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"8","key":"10.1016\/j.exer.2025.110364_bib34","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/aps.2010.98","article-title":"Novel vehicle based on cubosomes for ophthalmic delivery of flurbiprofen with low irritancy and high bioavailability","volume":"31","author":"Han","year":"2010","journal-title":"Acta Pharmacologica Sinica 2010"},{"issue":"1","key":"10.1016\/j.exer.2025.110364_bib35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0166-6622(87)80207-X","article-title":"Bile salts as biological surfactants","volume":"30","author":"Hofmann","year":"1987","journal-title":"Colloids Surf."},{"issue":"10","key":"10.1016\/j.exer.2025.110364_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-073411","volume":"13","author":"Hou","year":"2023","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.exer.2025.110364_bib37","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.nano.2013.08.012","article-title":"Improved stability and immunological potential of tetanus toxoid containing surface engineered bilosomes following oral administration","volume":"10","author":"Jain","year":"2014","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"2","key":"10.1016\/j.exer.2025.110364_bib38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejpb.2011.10.010","article-title":"Bioavailability enhancement of zaleplon via proliposomes: role of surface charge","volume":"80","author":"Janga","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"Suppl. 1","key":"10.1016\/j.exer.2025.110364_bib39","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1080\/21691401.2018.1443117","article-title":"Ion-sensitive in situ hydrogels of natamycin bilosomes for enhanced and prolonged ocular pharmacotherapy: in vitro permeability, cytotoxicity and in vivo evaluation","volume":"46","author":"Janga","year":"2018","journal-title":"Artif. Cell Nanomed. Biotechnol."},{"key":"10.1016\/j.exer.2025.110364_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2020.01.057","article-title":"Advances and limitations of drug delivery systems formulated as eye drops","volume":"321","author":"Jumelle","year":"2020","journal-title":"J. Contr. Release"},{"issue":"1\u20132","key":"10.1016\/j.exer.2025.110364_bib41","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijpharm.2011.04.027","article-title":"Spanlastics\u2014a novel nanovesicular carrier system for ocular delivery","volume":"413","author":"Kakkar","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.exer.2025.110364_bib42","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3109\/10837450.2012.685655","article-title":"A novel nanovesicular carrier system to deliver drug topically","volume":"18","author":"Kakkar","year":"2013","journal-title":"Pharmaceut. Dev. Technol."},{"issue":"6","key":"10.1016\/j.exer.2025.110364_bib43","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3390\/pharmaceutics16060697","article-title":"Emerging trends in bilosomes as therapeutic drug delivery systems","volume":"16","author":"Kaurav","year":"2024","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.exer.2025.110364_bib44","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3390\/pharmaceutics16060697","article-title":"Emerging trends in bilosomes as therapeutic drug delivery systems","volume":"16","author":"Kaurav","year":"2024","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.exer.2025.110364_bib45","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1080\/10717544.2022.2120925","article-title":"Pitavastatin-loaded bilosomes for oral treatment of hepatocellular carcinoma: a repurposing approach","volume":"29","author":"Kharouba","year":"2022","journal-title":"Drug Deliv."},{"issue":"21\u201322","key":"10.1016\/j.exer.2025.110364_bib46","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.drudis.2012.06.013","article-title":"Ultra-adaptable nanovesicular systems: a carrier for systemic delivery of therapeutic agents","volume":"17","author":"Kumar","year":"2012","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.exer.2025.110364_bib47","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.colsurfb.2014.02.007","article-title":"Preparation and optimization of voriconazole microemulsion for ocular delivery","volume":"117","author":"Kumar","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"1","key":"10.1016\/j.exer.2025.110364_bib48","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.4.1.1","article-title":"Nanosponge-mediated drug delivery lowers intraocular pressure","volume":"4","author":"Lambert","year":"2015","journal-title":"Translational Vision Science & Technology"},{"issue":"1\u20132","key":"10.1016\/j.exer.2025.110364_bib49","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijpharm.2010.10.013","article-title":"Nanostructured lipid carrier (NLC) coated with Chitosan Oligosaccharides and its potential use in ocular drug delivery system","volume":"403","author":"Luo","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.exer.2025.110364_bib50","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ymeth.2005.11.002","article-title":"Oral delivery of tetanus toxoid using vesicles containing bile salts (bilosomes) induces significant systemic and mucosal immunity","volume":"38","author":"Mann","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.exer.2025.110364_bib51","article-title":"Development of acetazolamide loaded bilosomes for improved ocular delivery: preparation, characterization and in vivo evaluation","volume":"59","author":"Mohsen","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.exer.2025.110364_bib52","doi-asserted-by":"crossref","first-page":"271","DOI":"10.31351\/vol32issSuppl.pp271-282","article-title":"Study the effect of formulation variables on preparation of nisoldipine loaded nano bilosomes","volume":"32","author":"Naji","year":"2023","journal-title":"Iraqi Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.exer.2025.110364_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3897\/pharmacia.71.e116917","article-title":"Evaluation of types and concentration of bile salts impact on physical properties of nisoldipine-loaded bilosomes","volume":"71","author":"Naji","year":"2024","journal-title":"Pharmacia"},{"issue":"1","key":"10.1016\/j.exer.2025.110364_bib54","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1021\/nn4046024","article-title":"Sustained drug release in nanomedicine: a long-acting nanocarrier-based formulation for glaucoma","volume":"8","author":"Natarajan","year":"2014","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.exer.2025.110364_bib55","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1080\/10717544.2022.2100513","article-title":"Hyaluronic acid-enriched bilosomes: an approach to enhance ocular delivery of agomelatine via D-optimal design: formulation, in vitro characterization, and in vivo pharmacodynamic evaluation in rabbits","volume":"29","author":"Nemr","year":"2022","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.exer.2025.110364_bib56","first-page":"41","article-title":"A comprehensive review on bilosome: a nano-vesicular drug delivery system to enhance bioavailability of the drug through different routes of administration","volume":"47","author":"Nemr","year":"2024","journal-title":"Bulletin of Pharmaceutical Sciences Assiut University"},{"issue":"1\u20132","key":"10.1016\/j.exer.2025.110364_bib57","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijpharm.2013.11.028","article-title":"Enhanced oral absorption of insulin-loaded liposomes containing bile salts: a mechanistic study","volume":"460","author":"Niu","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.exer.2025.110364_bib58","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2174\/1574885514666190917145510","article-title":"Bilosomes: superior vesicular carriers","volume":"15","author":"Palekar-Shanbhag","year":"2019","journal-title":"Curr. Drug Ther."},{"issue":"4","key":"10.1016\/j.exer.2025.110364_bib59","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000329603","article-title":"Epidemiology of major eye diseases leading to blindness in Europe: a literature review","volume":"47","author":"Prokofyeva","year":"2012","journal-title":"Ophthalmic Res."},{"issue":"11","key":"10.1016\/j.exer.2025.110364_bib60","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3390\/pharmaceutics16111376","article-title":"Lipid-based nanoformulations for drug delivery: an ongoing perspective","volume":"16","author":"Rehman","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.exer.2025.110364_bib61","article-title":"Bilosomes nanocarriers for improved oral bioavailability of acyclovir: a complete characterization through in vitro, ex-vivo and in vivo assessment","volume":"57","author":"Rizwanullah","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.exer.2025.110364_bib62","article-title":"Fabrication of betaxolol hydrochloride-loaded highly permeable ocular bilosomes (HPOBs) to combat glaucoma: in vitro, ex vivo & in vivo characterizations","volume":"82","author":"Sakr","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.exer.2025.110364_bib63","article-title":"Formulation and optimization of lornoxicam-loaded bilosomes using 23 full factorial design for the management of osteoarthritis in rats: modulation of MAPK\/Erk1 signaling pathway","volume":"69","author":"Salama","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"3","key":"10.1016\/j.exer.2025.110364_bib64","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.xphs.2022.10.001","article-title":"Budesonide-loaded bilosomes as a targeted delivery therapeutic approach against acute lung injury in rats","volume":"112","author":"Salem","year":"2023","journal-title":"J. Pharmaceut. Sci."},{"issue":"6","key":"10.1016\/j.exer.2025.110364_bib65","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5339\/jemtac.2024.absc.17","article-title":"Bilosome as a potential carrier for improving poor oral drug bioavailability","volume":"2024","author":"Salman","year":"2024","journal-title":"Journal of Emergency Medicine, Trauma and Acute Care"},{"key":"10.1016\/j.exer.2025.110364_bib66","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jconrel.2023.08.041","article-title":"An insight on ophthalmic drug delivery systems: focus on polymeric biomaterials-based carriers","volume":"362","author":"Shafiq","year":"2023","journal-title":"J. Contr. Release"},{"issue":"3","key":"10.1016\/j.exer.2025.110364_bib67","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2174\/0124681873274362231110055846","article-title":"A review: bilosomes as nanocarriers","volume":"14","author":"Sharma","year":"2023","journal-title":"Current Nanomedicine"},{"issue":"6","key":"10.1016\/j.exer.2025.110364_bib68","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.drudis.2016.03.013","article-title":"Bilosomes in the context of oral immunization: development, challenges and opportunities","volume":"21","author":"Shukla","year":"2016","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.exer.2025.110364_bib69","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ejmech.2009.10.017","article-title":"Designing dendrimers for ocular drug delivery","volume":"45","author":"Spataro","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.exer.2025.110364_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124741","article-title":"A one-platform comparison study of brinzolamide-loaded liposomes, niosomes, transfersomes, and transniosomes for better management of glaucoma","volume":"666","author":"Srivastava","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.exer.2025.110364_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103647","article-title":"Recent trends and updates on ultradeformable and elastic vesicles in ocular drug delivery","volume":"28","author":"Srivastava","year":"2023","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.exer.2025.110364_bib72","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3109\/10717541003667764","article-title":"Liposomes incorporating sodium deoxycholate for hexamethylmelamine (HMM) oral delivery: development, characterization, and in vivo evaluation","volume":"17","author":"Sun","year":"2010","journal-title":"Drug Deliv."},{"issue":"5","key":"10.1016\/j.exer.2025.110364_bib73","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.3390\/ma13051090","article-title":"Effect of UV and gamma irradiation sterilization processes in the properties of different polymeric nanoparticles for biomedical applications","volume":"13","author":"Tapia-Guerrero","year":"2020","journal-title":"Materials"},{"issue":"1","key":"10.1016\/j.exer.2025.110364_bib74","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40199-023-00500-z","article-title":"Development of brimonidine niosomes laden contact lenses for extended release and promising delivery system in glaucoma treatment","volume":"32","author":"Tripathi","year":"2024","journal-title":"Daru"},{"issue":"1\u20132","key":"10.1016\/j.exer.2025.110364_bib75","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijpharm.2014.03.048","article-title":"Brinzolamide nanocrystal formulations for ophthalmic delivery: reduction of elevated intraocular pressure in vivo","volume":"467","author":"Tuomela","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.exer.2025.110364_bib76","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.3390\/pharmaceutics14081695","article-title":"Linoleic acid-based transferosomes for topical ocular delivery of cyclosporine A","volume":"14","author":"Uwaezuoke","year":"2022","journal-title":"Pharmaceutics"},{"issue":"1\u20132","key":"10.1016\/j.exer.2025.110364_bib77","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0378-5173(01)00576-2","article-title":"Elasticity of vesicles assessed by electron spin resonance, electron microscopy and extrusion measurements","volume":"217","author":"Van Den Bergh","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.exer.2025.110364_bib78","article-title":"Quality by Design (QbD) enabled and Box-Behnken design assisted approach for formulation of tranexamic acid loaded stratum corneum lipid liposomes","volume":"86","author":"Verma","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.exer.2025.110364_bib79","article-title":"Bimatoprost: promising novel drug delivery systems in treatment of glaucoma","volume":"69","author":"Wadhwa","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"12","key":"10.1016\/j.exer.2025.110364_bib80","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.3390\/nano10122472","article-title":"Novel surface-modified bilosomes as functional and biocompatible nanocarriers of hybrid compounds","volume":"10","author":"Waglewska","year":"2020","journal-title":"Nanomaterials"},{"issue":"Suppl. 1","key":"10.1016\/j.exer.2025.110364_bib81","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1442-9071.2010.02363.x","article-title":"Anatomy and physiology of the human eye: effects of mucopolysaccharidoses disease on structure and function \u2013 a review","volume":"38","author":"Willoughby","year":"2010","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2025.110364_bib82","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.lfs.2019.02.029","article-title":"Glaucoma: current treatment and impact of advanced drug delivery systems","volume":"221","author":"Yadav","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.exer.2025.110364_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117303","article-title":"Bio-tactics for neuroprotection of retinal ganglion cells in the treatment of glaucoma","volume":"243","author":"Yadav","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.exer.2025.110364_bib84","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.biopha.2017.12.103","article-title":"Hyaluronic acid modified nanostructured lipid carriers for transdermal bupivacaine delivery: in vitro and in vivo anesthesia evaluation","volume":"98","author":"Yue","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.exer.2025.110364_bib85","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1080\/10717544.2021.2008055","article-title":"Development and evaluation of luteolin loaded pegylated bilosome: optimization, in vitro characterization, and cytotoxicity study","volume":"28","author":"Zafar","year":"2021","journal-title":"Drug Deliv."},{"issue":"7","key":"10.1016\/j.exer.2025.110364_bib86","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3390\/gels8070418","article-title":"Formulation and evaluation of moxifloxacin loaded bilosomes in-situ gel: optimization to antibacterial evaluation","volume":"8","author":"Zafar","year":"2022","journal-title":"Gels"},{"issue":"3","key":"10.1016\/j.exer.2025.110364_bib87","doi-asserted-by":"crossref","first-page":"646","DOI":"10.34172\/apb.2024.057","article-title":"Development of gentamicin bilosomes laden in situ gel for topical ocular delivery: optimization, in vitro characterization, toxicity, and anti-microbial evaluation","volume":"14","author":"Zafar","year":"2024","journal-title":"Adv. Pharmaceut. Bull."},{"issue":"2","key":"10.1016\/j.exer.2025.110364_bib88","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/gels8020133","article-title":"Formulation and evaluation of topical nano-lipid-based delivery of butenafine: in vitro characterization and antifungal activity","volume":"8","author":"Zafar","year":"2022","journal-title":"Gels"},{"key":"10.1016\/j.exer.2025.110364_bib89","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/734527","article-title":"Pathogenesis of common ocular diseases","volume":"2015","author":"Zhang","year":"2015","journal-title":"Journal of Ophthalmology"},{"issue":"5","key":"10.1016\/j.exer.2025.110364_bib90","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.bpj.2009.06.025","article-title":"Roles of cholesterol in vesicle fusion and motion","volume":"97","author":"Zhang","year":"2009","journal-title":"Biophys. J."},{"issue":"1","key":"10.1016\/j.exer.2025.110364_bib91","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16010125","article-title":"Formulating resveratrol and melatonin self-nanoemulsifying drug delivery systems (SNEDDS) for ocular administration using design of experiments","volume":"16","author":"Zingale","year":"2024","journal-title":"Pharmaceutics"}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483525001356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483525001356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:12:47Z","timestamp":1778040767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483525001356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":91,"alternative-id":["S0014483525001356"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2025.110364","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bilosomes as a novel ocular drug delivery system: Assessing the material attributes, process parameters, and quality attributes","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2025.110364","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110364"}}